News Focus
News Focus
Followers 2421
Posts 92347
Boards Moderated 1
Alias Born 09/12/2003

Re: ash111 post# 514

Saturday, 06/01/2013 3:53:30 AM

Saturday, June 01, 2013 3:53:30 AM

Post# of 554
It's really don't matter for NGX-1998 Phase 3 development. They going to sell all the asset and shares holders getting nothing eom

As of April 15, 2013, NeurogesX, Inc. (the “NeurogesX”) and Acorda Therapeutics, Inc. (“Acorda”) entered into an Asset Purchase Agreement (the “APA”). Pursuant to the terms of the APA, Acorda will acquire at the closing certain assets of NeurogesX (including NeurogesX’ assets relating to its product Qutenza and its product candidate NGX-1998),

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today